Position in RPRX
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$561,573,456
-$213,414,368 QoQ
Shares Held
10,015,578
-38.0% QoQ
Ownership
1.74%
of shares outstanding
% of Portfolio
0.51%
of 13F equity value
Holder Rank
#8
of 644 holders
Holding Since
Mar 2022
18 quarters on record
Voting authority
Sole 79%
Shared 0%
None 21%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BAILLIE GIFFORD & CO holds $3,256,235,173 across 13 Biotechnology names. RPRX ranks #3 (17.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRNA |
Moderna, Inc.
|
18,206,778 | $1,275,020,662 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,439,889 | $734,479,783 | |
| 3 | RPRX |
Royalty Pharma plc
This page
|
10,015,578 | $561,573,456 | |
| 4 | DNLI |
Denali Therapeutics Inc.
|
11,960,230 | $307,617,113 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
272,561 | $135,389,224 | |
| 6 | RXRX |
Recursion Pharmaceuticals, Inc.
|
23,487,907 | $86,200,617 | |
| 7 | BNTX |
BioNTech SE
|
592,380 | $55,120,957 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
263,466 | $49,341,910 |
All Filings in RPRX
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $561,573,456 | 10,015,578 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $774,987,824 | 16,155,677 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $657,218,793 | 17,008,768 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $612,901,868 | 17,372,502 | Shares | Defined | 2025-10-31 | |
| 2025-06-30 | $649,276,992 | 18,020,455 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $417,213,099 | 13,402,284 | Shares | Defined | 2025-05-07 | |
| 2024-12-31 | $360,571,501 | 14,134,516 | Shares | Defined | 2025-01-31 | |
| 2024-09-30 | $456,105,268 | 16,122,491 | Shares | Defined | 2024-11-05 | |
| 2024-06-30 | $431,222,253 | 16,352,759 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $506,048,992 | 16,662,792 | Shares | Defined | 2024-05-01 | |
| 2023-12-31 | $494,115,738 | 17,590,450 | Shares | Defined | 2024-01-26 | |
| 2023-09-30 | $495,068,445 | 18,241,284 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $568,708,073 | 18,500,588 | Shares | Sole | 2023-07-28 | |
| 2023-03-31 | $681,642,561 | 18,918,750 | Shares | Defined | 2023-05-03 | |
| 2022-12-31 | $676,554,023 | 17,119,282 | Shares | Defined | 2023-03-10 | |
| 2022-09-30 | $717,943,270 | 17,868,175 | Shares | Defined | 2022-10-27 | |
| 2022-06-30 | $756,506,350 | 17,994,918 | Shares | Defined | 2022-08-08 | |
| 2022-03-31 | $43,909,126 | 1,127,031 | Shares | Defined | 2022-05-05 | |
| No filing history on record for this holder in this stock. | ||||||